Functional homology of gHs and gLs from EBV-related γ-herpesviruses for EBV-induced membrane fusion

Virology

Volumn 365, Issue 1, 2007, Pages 157-165

  Omerović, Jasmina ^a   Longnecker, Richard ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cross virus complementation; Epstein Barr virus; Fusion; Glycoprotein gH; Glycoprotein gL; Glycoprotein gp42; HHV8; Lymphocryptovirus

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN GH; GLYCOPROTEIN GL; GLYCOPROTEIN GP42; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL FUSION; CELL SURFACE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HERPES VIRUS; MARMOSET; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; B-LYMPHOCYTES; CHO CELLS; CRICETINAE; CRICETULUS; EPITHELIAL CELLS; GLYCOPROTEINS; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; MEMBRANE FUSION; VIRAL PROTEINS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; LYMPHOCRYPTOVIRUS; MARMOSETS; PRIMATES;

EID: 34250173466     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.03.054     Document Type: Article

References (40)

1. Balachandran N., Oba D.E., and Hutt-Fletcher L.M. Antigenic cross-reactions among herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus. J. Virol. 61 4 (1987) 1125-1135
2. Borza C.M., Morgan A.J., Turk S.M., and Hutt-Fletcher L.M. Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection. J. Virol. 78 10 (2004) 5007-5014
3. Cho Y.G., Gordadze A.V., Ling P.D., and Wang F. Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus. J. Virol. 73 11 (1999) 9206-9212
4. Cho Y., Ramer J., Rivailler P., Quink C., Garber R.L., Beier D.R., and Wang F. An Epstein-Barr-related herpesvirus from marmoset lymphomas. Proc. Natl. Acad. Sci. U. S. A. 98 3 (2001) 1224-1229
5. Damania B., and Desrosiers R.C. Simian homologues of human herpesvirus 8. Philos. Trans. R. Soc. Lond., B Biol. Sci. 356 1408 (2001) 535-543
6. Dubin G., and Jiang H. Expression of herpes simplex virus type 1 glycoprotein L (gL) in transfected mammalian cells: evidence that gL is not independently anchored to cell membranes. J. Virol. 69 7 (1995) 4564-4568
7. Duus K.M., and Grose C. Multiple regulatory effects of Varicella-Zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH. J. Virol. 70 12 (1996) 8961-8971
8. Ehlers B., Ochs A., Leendertz F., Goltz M., Boesch C., and Matz-Rensing K. Novel simian homologues of Epstein-Barr virus. J. Virol. 77 19 (2003) 10695-10699
9. Gupta A.K., Ruvolo V., Patterson C., and Swaminathan S. The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression. J. Virol. 74 2 (2000) 1038-1044
10. Haan K.M., Lee S.K., and Longnecker R. Different functional domains in the cytoplasmic tail of glycoprotein B are involved in Epstein-Barr virus-induced membrane fusion. Virology 290 1 (2001) 106-114
11. Kieff E., and Rickinson A.B. Esptein-Barr virus. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. 4th ed. vol. 2 (2001), Lippincott Williams and Wilkins, Philadelphia, PA 2575-2627
12. Kirschner A.N., Omerovic J., Popov B., Longnecker R., and Jardetzky T.S. Soluble Epstein-Barr virus glycoproteins gH, gL, and gp42 form a 1:1:1 stable complex that acts like soluble gp42 in B-cell fusion but not in epithelial cell fusion. J. Virol. 80 19 (2006) 9444-9454
13. Li Q., Turk S.M., and Hutt-Fletcher L.M. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J. Virol. 69 7 (1995) 3987-3994
14. Li Q., Buranathai C., Grose C., and Hutt-Fletcher L.M. Chaperone functions common to nonhomologous Epstein-Barr virus gL and Varicella-Zoster virus gL proteins. J. Virol. 71 2 (1997) 1667-1670
15. Li Q., Spriggs M.K., Kovats S., Turk S.M., Comeau M.R., Nepom B., and Hutt-Fletcher L.M. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol. 71 6 (1997) 4657-4662
16. Lin S.F., Sun R., Heston L., Gradoville L., Shedd D., Haglund K., Rigsby M., and Miller G. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J. Virol. 71 4 (1997) 3069-3076
17. Lukac D.M., Renne R., Kirshner J.R., and Ganem D. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252 2 (1998) 304-312
18. McShane M.P., and Longnecker R. Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins. Proc. Natl. Acad. Sci. U.S.A. 101 50 (2004) 17474-17479
19. Moghaddam A., Koch J., Annis B., and Wang F. Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus. J. Virol. 72 4 (1998) 3205-3212
20. Moore P.S., Gao S.J., Dominguez G., Cesarman E., Lungu O., Knowles D.M., Garber R., Pellett P.E., McGeoch D.J., and Chang Y. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J. Virol. 70 1 (1996) 549-558
21. Okuma K., Nakamura M., Nakano S., Niho Y., and Matsuura Y. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay. Virology 254 2 (1999) 235-244
22. Omerovic J., Lev L., and Longnecker R. The amino terminus of Epstein-Barr virus glycoprotein gH is important for fusion with epithelial and B cells. J. Virol. 79 19 (2005) 12408-12415
23. Pertel P.E. Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion. J. Virol. 76 9 (2002) 4390-4400
24. Pertel P.E., Spear P.G., and Longnecker R. Human herpesvirus-8 glycoprotein B interacts with Epstein-Barr virus (EBV) glycoprotein 110 but fails to complement the infectivity of EBV mutants. Virology 251 2 (1998) 402-413
25. Pulford D., Lowrey P., and Morgan A.J. Expression of the Epstein-Barr virus envelope fusion glycoprotein gp85 gene by a recombinant baculovirus. J. Gen. Virol. 75 Pt. 11 (1994) 3241-3248
26. Pulford D.J., Lowrey P., and Morgan A.J. Co-expression of the Epstein-Barr virus BXLF2 and BKRF2 genes with a recombinant baculovirus produces gp85 on the cell surface with antigenic similarity to the native protein. J. Gen. Virol. 76 Pt. 12 (1995) 3145-3152
27. Rivailler P., Cho Y.G., and Wang F. Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses. J. Virol. 76 23 (2002) 12055-12068
28. Rivailler P., Jiang H., Cho Y.G., Quink C., and Wang F. Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model. J. Virol. 76 1 (2002) 421-426
29. Russo J.J., Bohenzky R.A., Chien M.C., Chen J., Yan M., Maddalena D., Parry J.P., Peruzzi D., Edelman I.S., Chang Y., and Moore P.S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U.S.A. 93 25 (1996) 14862-14867
30. Silva A.L., Omerovic J., Jardetzky T.S., and Longnecker R. Mutational analyses of Epstein-Barr virus glycoprotein 42 reveal functional domains not involved in receptor binding but required for membrane fusion. J. Virol. 78 11 (2004) 5946-5956
31. Spear P.G., and Longnecker R. Herpesvirus entry: an update. J. Virol. 77 19 (2003) 10179-10185
32. Speck P., Haan K.M., and Longnecker R. Epstein-Barr virus entry into cells. Virology 277 1 (2000) 1-5
33. Strnad B.C., Schuster T., Klein R., Hopkins III R.F., Witmer T., Neubauer R.H., and Rabin H. Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen. J. Virol. 41 1 (1982) 258-264
34. Sun R., Lin S.F., Gradoville L., Yuan Y., Zhu F., and Miller G. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. U.S.A. 95 18 (1998) 10866-10871
35. Wang F. Epstein-Barr virus related lymphocryptoviruses of old and new world nonhuman primates. In: Robertson E.S. (Ed). Epstein-Barr Virus (2005), Caister Academic Press, Norfolk, England 691-709
36. Wang X., Kenyon W.J., Li Q., Mullberg J., and Hutt-Fletcher L.M. Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J. Virol. 72 7 (1998) 5552-5558
37. Wang F., Rivailler P., Rao P., and Cho Y. Simian homologues of Epstein-Barr virus. Philos. Trans. R. Soc. Lond., B Biol. Sci. 356 1408 (2001) 489-497
38. Wu L., and Hutt-Fletcher L.M. Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion. Virology (2007) 10.1016/j.virol.2007.01.025
39. Wu L., Borza C.M., and Hutt-Fletcher L.M. Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells. J. Virol. 79 17 (2005) 10923-10930
40. Yaswen L.R., Stephens E.B., Davenport L.C., and Hutt-Fletcher L.M. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein. Virology 195 2 (1993) 387-396